Personalized treatment strategies based on genetics at diagnosis

Can genetic information from diagnostic biopsies reveal the most effective treatments for each myeloma patient?

Go directly to survey

STUDY IMPACT

Every myeloma patient is unique — their treatment should be too. Your biopsy slides may be sitting in a drawer today, but they hold genetic clues that can help researchers match patients with the therapies that work best for them. Those slides can become part of the progress that transforms how myeloma is treated.

The University of Miami team is working with HealthTree to build CORAL, an improved version of their IRMMa model. This tool is designed to help newly diagnosed patients understand their best treatment path based on genetics at diagnosis. They’ve made strong progress, but to create an accurate, personalized model, they need thousands of patients from across the community, not just one institution.

Research Partners

WHO CAN JOIN

Multiple myeloma patients willing to share 5 unstained slides from their original bone marrow biopsy and willing to connect their medical records

HOW TO PARTICIPATE

1. Sign in or create a free HealthTree Cure Hub account.
2. Sign the consent form and tell us where your first bone marrow biopsy (BMB) from your multiple myeloma diagnosis was done.
3. Connect your medical records (this takes less than 5 minutes).

REQUIREMENTS

• Diagnosed with active multiple myeloma (MM).,
• Bone marrow biopsy sample from diagnosis, taken before starting treatment, stored at one or more multiple myeloma treating medical centers.,
• Have a HealthTree Cure Hub account with imported electronic medical records (EHR).

Join the Study Today

ABOUT HEALTHTREE CURE HUB